• Nu Skin held its annual stockholders meeting on May 28, 2026.
• Stockholders adopted an amended and restated 2024 Omnibus Incentive Plan, increasing the share authorization by 2,850,000 shares.
• The plan’s termination date was extended to May 28, 2036; the filing does not indicate any awards were granted or other actions executed.
• Stockholders backed the company’s director slate.
• Stockholders ratified PricewaterhouseCoopers as independent auditor for 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nu Skin Enterprises Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-023312), on May 29, 2026, and is solely responsible for the information contained therein.